Shares of life sciences company Azenta (NASDAQ:AZTA) jumped 3.3% in the afternoon session after an upgrade from investment ...

Shares of life sciences company Azenta (NASDAQ:AZTA) fell 16.3% in the afternoon session after the company announced mixed ...

What Happened? Shares of life sciences company Azenta (NASDAQ:AZTA) jumped 5% in the afternoon session after Raymond James ...

Life sciences company Azenta (NASDAQ:AZTA) fell short of the market’s revenue expectations in Q2 CY2025, with sales flat year ...

Azenta, Inc. ( NASDAQ: AZTA) Q3 2025 Earnings Conference Call August 6, 2025 8:30 AM ET John P. Marotta - President, CEO & Director Lawrence Y. Lin - Executive VP & CFO Yvonne Perron - Vice President ...

Azenta, Inc. shares have surged over 30% since Nov 2024 due to S&P 600 inclusion and an analyst upgrade, despite somewhat tepid growth prospects. Read more here.

Unfortunately, Azenta's stock has a premium valuation in a market that is favoring classic value plays. Underscoring this point, the company's shares are trading at over seven times 2023 projected ...

Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the ...

Shares of Azenta Inc. AZTA jumped 11.9% after hours on Monday after the life-sciences company reported fourth-quarter results that beat expectations and announced plans to buy back an extra $500 ...

Nov 1 (Reuters) - Activist investor Politan Capital Management has nominated candidates to Azenta's board and is working with the biotechnology company to address certain issues, a company filing ...

Azenta Inc. , formerly known as life sciences solutions company Brooks Automation Inc., said Wednesday that its stock will begin trading under a new ticker -- "AZTA" -- after the opening bell.